Author
Queen Mary University of LondonORCID 0000-0002-8505-7430Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Filip Filipsky, Katarina B. Chapman, Johannes Bloehdorn…·Tetyana Klymenko
This study shows that Lamin B1 protects B cell genomes by preventing DNA damage and regulating chromatin accessibility, with its loss linked to poor lymphoma outcomes.
Michael James Austin, Shruti Patel, Ronas Taner Kesmez…·Bela G. Patel
This study identifies ASS1 deficiency as a therapeutic target in Ph+ ALL, showing arginine deprivation induces apoptosis and overcomes TKI resistance.
Fadimana Kaya, Findlay Bewicke‐Copley, Juho Jalmari Miettinen…·Ana Rio‐Machín
This study identifies DEK::NUP214 as an XPO1-dependent transcriptional activator of leukemia genes, showing selective response to XPO1 inhibitors in t(6;9) AML cases.
James A. Aries, Sarah Charrot, Symeon Theocharidis…·JEFF K. DAVIES
The paper uses mass cytometry to identify immune cell signatures predictive of acute graft-versus-host disease (aGvHD) and shows how these signatures evolve over time.
Pedro Casado, Ana Rio‐Machín, Juho Jalmari Miettinen…·Pedro R. Cutillas
The paper identifies two distinct subgroups of KMT2A-rearranged AML using phosphoproteomics and shows different drug response profiles.